Search research articles
Contact Us
Filters
Showing results (11-20 of 156) with videos related to
Page
of 16
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 22, 2001
Fondaparinux sodium: a selective inhibitor of factor Xa
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
July 26, 2011
Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa
K A Bauer
Bailliere'S Best Practice & Research. Clinical Haematology
|
June 17, 2000
Activation markers of coagulation
K A Bauer
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|
January 1, 1997
[Treatment and prevention of thrombotic episodes with hereditary thrombophilia]
K A Bauer
Thrombosis and Haemostasis
|
July 1, 1995
Management of patients with hereditary defects predisposing to thrombosis including pregnant women
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Management of thrombophilia
K A Bauer
Annals of Internal Medicine
|
September 1, 2001
The thrombophilias: well-defined risk factors with uncertain therapeutic implications
K A Bauer
The New England Journal of Medicine
|
February 24, 1994
Hypercoagulability--a new cofactor in the protein C anticoagulant pathway
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
September 4, 2007
Targeted inhibition of coagulation: oral agents show promise in phase III trials
K A Bauer
Seminars in Thrombosis and Hemostasis
|
November 25, 2000
Recombinant factor VIIa for the treatment of congenital factor VII deficiency
M Hunault, K A Bauer
Page
of 16
Search research articles
Search
Showing results (11-20 of 156) with videos related to
Sort By:
Page
of 16
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 22, 2001
Fondaparinux sodium: a selective inhibitor of factor Xa
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
July 26, 2011
Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa
K A Bauer
Bailliere'S Best Practice & Research. Clinical Haematology
|
June 17, 2000
Activation markers of coagulation
K A Bauer
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|
January 1, 1997
[Treatment and prevention of thrombotic episodes with hereditary thrombophilia]
K A Bauer
Thrombosis and Haemostasis
|
July 1, 1995
Management of patients with hereditary defects predisposing to thrombosis including pregnant women
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Management of thrombophilia
K A Bauer
Annals of Internal Medicine
|
September 1, 2001
The thrombophilias: well-defined risk factors with uncertain therapeutic implications
K A Bauer
The New England Journal of Medicine
|
February 24, 1994
Hypercoagulability--a new cofactor in the protein C anticoagulant pathway
K A Bauer
Journal of Thrombosis and Haemostasis : JTH
|
September 4, 2007
Targeted inhibition of coagulation: oral agents show promise in phase III trials
K A Bauer
Seminars in Thrombosis and Hemostasis
|
November 25, 2000
Recombinant factor VIIa for the treatment of congenital factor VII deficiency
M Hunault, K A Bauer
Page
of 16